Rehabilitating rimonabant.
Friedrich C Luft
Author Information
- Friedrich C Luft: Experimental and Clinical Research Center, and Max-Delbrück Center, Lindenbergerweg 80, 13125 Berlin, Germany. luft@charite.de
No abstract text available.
- Proc Natl Acad Sci U S A. 1999 May 11;96(10):5780-5
[PMID: 10318961]
- Int J Obes (Lond). 2009 Sep;33(9):947-55
[PMID: 19597516]
- J Am Coll Cardiol. 2010 Dec 14;56(25):2115-25
[PMID: 21144973]
- Life Sci. 2006 Jan 2;78(6):549-63
[PMID: 16109430]
- Prog Lipid Res. 2011 Apr;50(2):193-211
[PMID: 21295074]
- Trends Pharmacol Sci. 2012 Jun;33(6):331-40
[PMID: 22503477]
- J Mol Med (Berl). 2013 Jul;91(7):811-23
[PMID: 23636507]
- J Am Coll Cardiol. 2007 Aug 7;50(6):528-36
[PMID: 17678736]
- Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14136-41
[PMID: 10570211]
- Pharmacol Ther. 2005 May;106(2):133-45
[PMID: 15866316]
- Basic Res Cardiol. 2009 Nov;104(6):781-92
[PMID: 19462153]
- Arch Gen Psychiatry. 2001 Apr;58(4):322-8
[PMID: 11296091]
- Mol Pharmacol. 2008 Feb;73(2):441-50
[PMID: 17965195]
- Pharmacol Rev. 2002 Jun;54(2):161-202
[PMID: 12037135]
Animals
Cannabinoid Receptor Antagonists
Humans
Piperidines
Pyrazoles
Receptor, Cannabinoid, CB1
Rimonabant
Cannabinoid Receptor Antagonists
Piperidines
Pyrazoles
Receptor, Cannabinoid, CB1
Rimonabant
